Aeglea BioTherapeutics Inc.

(AGLE) Trade

By |

Profile

Aeglea BioTherapeutics Inc is a biopharmaceutical company committed to developing enzyme-based therapeutics in the field of amino acid metabolism, which will transform the lives of patients with inborn errors of metabolism and cancer.

Contact Information

Website: www.aegleabio.com
Email: investors@aegleabio.com
Main Phone: +1 512 942-2935
Address: 901 S. MoPac Expressway
Address 2: Suite 250, Barton Oaks Plaza One
State: TX
City / Town: Austin
Country: USA
Postal Code: 78746

Issuer Information

Exchange: NSD
CEO: Anthony G. Quinn
Employees: 43
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 9.36 $ 0.32 (3.54%)
Last Price 9.36 Change $ 0.32 Change % 3.54 Tick N/A
Bid 5.15 Bid Size 100.00 Ask 11.95 Ask Size 2,000.00
Open 9.02 High 9.50 Low 8.96 Prev Close 9.04
Last Trade Volume 246,832 52 Wk Hi 12.00 52 Wk Low 2.81
Market Cap 204.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 21,858,874.00 EPS (TTM) -1.82 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 11
Number of Buys 0 11
Number of Sells 0 0
Net Activity 0 62579
Last 10 Buys Shares
Anthony G. Quinn 1,000
Anthony G. Quinn 1,000
Anthony G. Quinn 1,000
Charles N. York 1,000
Anthony G. Quinn 1,000
Charles N. York 1,000
Anthony G. Quinn 1,000
Charles N. York 1,000
Anthony G. Quinn 1,000
Charles N. York 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 37 37 37 37
Low Target Price Estimate 12 12 12 12
Mean Target Price Estimate 24.33 24.33 24.33 24.33
Standard Deviation 12.5 12.5 12.5 12.5
Date of Most Recent Estimate 04/24/18 04/24/18 04/24/18 04/24/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 2 2
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.25 1.25 1.33 1.33